![ANET - Arista Networks Inc - Stock Price Chart]() |
| Market Cap | 178.77B | EPS (TTM) | 2.92 |
| P/E | 48.61 | EPS this Y | 21.88% |
| Forward P/E | 31.94 | EPS next Y | 22.38% |
| PEG | 1.47 | EPS past 5Y | 40.70% |
| P/S | 18.41 | EPS next 5Y | 21.79% |
| P/B | 13.25 | EPS Q/Q | 26.22% |
| Dividend | - | Sales Q/Q | 35.13% |
| Insider Own | 17.24% | Inst Own | 70.76% |
| Insider Trans | -0.79% | Inst Trans | 1.20% |
| Short Float | 1.76% | Earnings | May 05/a |
| Analyst Recom | 1.12 | Target Price | 188.18 |
| Avg Volume | 8.56M | 52W Range | 83.86 - 179.80 |
|
|
| May-15-26 | Upgrade |
Raymond James |
Mkt Perform → Outperform |
$164 |
|
|
|
Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include Core, Cognitive Adjacencies, and Network Software and Services. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Giancarlo Charles H | Director | May 01 '26 | Sale | 175.40 | 8,000 | 1,403,202 | 208,333 | May 05 05:52 PM | | Charles Giancarlo | Director | May 01 '26 | Proposed Sale | 172.71 | 24,000 | 4,145,040 | | May 01 04:05 PM | | Ullal Jayshree | CEO and Chairperson | Apr 22 '26 | Sale | 177.44 | 428,000 | 75,944,314 | 5,209,207 | Apr 24 06:30 PM | | Ullal Jayshree | CEO and Chairperson | Apr 21 '26 | Sale | 168.57 | 93,861 | 15,822,499 | 5,273,207 | Apr 23 06:17 PM | | Ullal Jayshree | CEO and Chairperson | Apr 20 '26 | Sale | 167.31 | 306,139 | 51,220,728 | 5,287,287 | Apr 22 07:09 PM |
|
|
 |
![AVAH - Aveanna Healthcare Holdings Inc - Stock Price Chart]() |
| Market Cap | 1.68B | EPS (TTM) | 1.18 |
| P/E | 6.55 | EPS this Y | 12.64% |
| Forward P/E | 10.46 | EPS next Y | 9.21% |
| PEG | 0.90 | EPS past 5Y | - |
| P/S | 0.67 | EPS next 5Y | 11.57% |
| P/B | 7.00 | EPS Q/Q | 644.05% |
| Dividend | - | Sales Q/Q | 15.86% |
| Insider Own | 62.77% | Inst Own | 33.38% |
| Insider Trans | -0.73% | Inst Trans | 3.97% |
| Short Float | 3.61% | Earnings | May 14/b |
| Analyst Recom | 1.75 | Target Price | 9.95 |
| Avg Volume | 1.34M | 52W Range | 3.73 - 10.32 |
|
|
| May-15-26 | Upgrade |
Stephens |
Equal-Weight → Overweight |
$11 |
|
|
|
Aveanna Healthcare Holdings, Inc. engages in providing home care services to patients. It operates through the following business segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment includes private duty nursing services. The HHH segment provides home health, hospice, and program services to predominately elderly populations. The MS segment offers supplies to patients requiring enteral nutrition services or respiratory care. The company was founded on November 30, 2016 and is headquartered in Atlanta, GA. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Shaner Jeff | Chief Executive Officer | Feb 19 '26 | Sale | 7.21 | 173,225 | 1,248,640 | 2,650,892 | Feb 19 09:16 PM | | Shaner Jeff | Chief Executive Officer | Feb 18 '26 | Sale | 7.38 | 168,800 | 1,246,234 | 2,824,117 | Feb 19 09:16 PM | | Shaner Jeff | Chief Executive Officer | Feb 17 '26 | Sale | 7.65 | 119,884 | 916,525 | 2,992,917 | Feb 19 09:16 PM | | Cunningham Patrick A. | Chief Compliance Officer | Feb 19 '26 | Sale | 7.21 | 18,436 | 132,890 | 337,755 | Feb 19 09:15 PM | | Cunningham Patrick A. | Chief Compliance Officer | Feb 18 '26 | Sale | 7.38 | 17,965 | 132,634 | 356,191 | Feb 19 09:15 PM |
|
|
 |
![RCEL - AVITA Medical Inc - Stock Price Chart]() |
| Market Cap | 113.27M | EPS (TTM) | -1.57 |
| P/E | - | EPS this Y | 39.77% |
| Forward P/E | - | EPS next Y | 58.31% |
| PEG | - | EPS past 5Y | 3.38% |
| P/S | 1.57 | EPS next 5Y | - |
| P/B | - | EPS Q/Q | 34.19% |
| Dividend | - | Sales Q/Q | 3.98% |
| Insider Own | 1.15% | Inst Own | 20.61% |
| Insider Trans | 1.06% | Inst Trans | -0.87% |
| Short Float | 13.91% | Earnings | May 14/a |
| Analyst Recom | 1.75 | Target Price | 6.97 |
| Avg Volume | 224.99K | 52W Range | 3.22 - 7.12 |
|
|
| May-15-26 | Upgrade |
Lake Street |
Hold → Buy |
$6 |
|
|
|
AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company was founded in December 1992 and is headquartered in Valencia, CA. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| O'Toole David D | CFO | Feb 19 '26 | Buy | 4.15 | 3,000 | 12,450 | 140,127 | Feb 23 04:30 PM | | McNamara Robert | Director | Aug 28 '25 | Buy | 4.50 | 10,000 | 45,000 | 86,771 | Aug 29 04:30 PM | | O'Toole David D | CFO | Aug 26 '25 | Buy | 4.52 | 2,000 | 9,040 | 31,657 | Aug 26 04:30 PM | | McNamara Robert | Director | Aug 19 '25 | Buy | 5.00 | 10,000 | 50,000 | 76,771 | Aug 20 06:11 PM | | O'Toole David D | CFO | Aug 12 '25 | Buy | 4.81 | 2,000 | 9,620 | 29,657 | Aug 12 04:30 PM |
|
|
|  |
![BWXT - BWX Technologies Inc - Stock Price Chart]() |
| Market Cap | 18.76B | EPS (TTM) | 3.75 |
| P/E | 54.59 | EPS this Y | 17.23% |
| Forward P/E | 39.18 | EPS next Y | 11.15% |
| PEG | 2.92 | EPS past 5Y | 4.23% |
| P/S | 5.55 | EPS next 5Y | 13.41% |
| P/B | 14.65 | EPS Q/Q | 20.62% |
| Dividend | 0.53% | Sales Q/Q | 26.20% |
| Insider Own | 0.37% | Inst Own | 94.48% |
| Insider Trans | -7.06% | Inst Trans | -1.83% |
| Short Float | 3.18% | Earnings | May 04/a |
| Analyst Recom | 1.94 | Target Price | 240.17 |
| Avg Volume | 1.02M | 52W Range | 106.22 - 241.82 |
|
|
| May-15-26 | Upgrade |
Deutsche Bank |
Hold → Buy |
$255 |
|
|
|
BWX Technologies, Inc. engages in the supply and provision of nuclear components and products. It operates through the Government Operations and Commercial Operations segments. The Government Operations segment manufactures naval nuclear reactors, including the related nuclear fuel, for the U.S. Naval Nuclear Propulsion Program for use in submarines and aircraft carriers. The Commercial Operations segment fabricates commercial nuclear steam generators, nuclear fuel, fuel handling systems, pressure vessels, reactor components, heat exchangers, tooling delivery systems, and other auxiliary equipment, including containers for the storage of spent nuclear fuel and other high-level waste and supplies nuclear-grade materials and precisely machined components for nuclear utility customers. The company was founded by Stephen Wilcox and George Babcock in 1867 and is headquartered in Lynchburg, VA. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Geveden Rex D | President and CEO | May 12 '26 | Sale | 204.81 | 10,000 | 2,048,124 | 202,491 | May 12 04:55 PM | | Fitzgerald Michael Thomas | SVP & Chief Financial Officer | May 11 '26 | Option Exercise | 102.99 | 2,417 | 248,918 | 9,301 | May 12 04:25 PM | | Fitzgerald Michael Thomas | SVP & Chief Financial Officer | May 11 '26 | Sale | 209.25 | 2,417 | 505,757 | 6,884 | May 12 04:25 PM | | Geveden Rex D | Officer | May 12 '26 | Proposed Sale | 204.81 | 10,000 | 2,048,124 | | May 12 04:04 PM | | Fitzgerald Michael Thomas | Officer | May 11 '26 | Proposed Sale | 209.25 | 2,417 | 505,757 | | May 11 04:09 PM |
|
|
 |
![CHRW - C.H. Robinson Worldwide Inc - Stock Price Chart]() |
| Market Cap | 19.28B | EPS (TTM) | 4.94 |
| P/E | 33.11 | EPS this Y | 21.00% |
| Forward P/E | 22.27 | EPS next Y | 19.28% |
| PEG | 1.36 | EPS past 5Y | 5.38% |
| P/S | 1.19 | EPS next 5Y | 16.36% |
| P/B | 11.34 | EPS Q/Q | 9.65% |
| Dividend | 1.54% | Sales Q/Q | -0.84% |
| Insider Own | 0.69% | Inst Own | 109.34% |
| Insider Trans | -2.50% | Inst Trans | 5.52% |
| Short Float | 6.33% | Earnings | Apr 29/a |
| Analyst Recom | 2.00 | Target Price | 199.39 |
| Avg Volume | 1.92M | 52W Range | 92.36 - 203.34 |
|
|
| May-15-26 | Upgrade |
Citigroup |
Neutral → Buy |
$199 |
|
|
|
C.H. Robinson Worldwide, Inc. engages in the provision of freight transportation services and logistics solutions. It operates through the following segments: North American Surface Transportation (NAST), Global Forwarding, and All Other and Corporate. The NAST segment provides freight transportation services across North America through a network of offices in the United States, Canada, and Mexico. The Global Forwarding segment focuses on the global logistics services through an international network of offices in North America, Europe, Asia, Australia, New Zealand, and South America. The All Other and Corporate segment includes Robinson Fresh and Managed Services segments, as well as other surface transportation outside of North America and other miscellaneous revenues and unallocated corporate expenses. The company was founded by Charles Henry Robinson in 1905 and is headquartered in Eden Prairie, MN. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Castagnetto Michael D. | Pres, NAST | Feb 12 '26 | Buy | 168.24 | 594 | 100,000 | 35,488 | Feb 13 05:04 PM | | Bozeman David P | President & CEO | Feb 12 '26 | Buy | 163.34 | 1,223 | 199,771 | 190,600 | Feb 13 04:45 PM | | RAJAN ARUN | Chief Strat & Innov Officer | Feb 12 '26 | Buy | 167.11 | 605 | 101,102 | 133,656 | Feb 13 04:43 PM | | Lee Damon J. | Chief Financial Officer | Feb 12 '26 | Buy | 162.52 | 620 | 100,764 | 41,364 | Feb 13 04:41 PM | | Freeman Angela K. | CHRO and ESG Officer | Feb 09 '26 | Sale | 200.52 | 8,579 | 1,720,261 | 55,611 | Feb 11 06:02 PM |
|
|
|  |
![CSCO - Cisco Systems Inc - Stock Price Chart]() |
| Market Cap | 466.92B | EPS (TTM) | 3.07 |
| P/E | 38.50 | EPS this Y | 11.72% |
| Forward P/E | 25.00 | EPS next Y | 11.10% |
| PEG | 2.32 | EPS past 5Y | -0.69% |
| P/S | 7.69 | EPS next 5Y | 10.79% |
| P/B | 9.78 | EPS Q/Q | 36.57% |
| Dividend | 1.40% | Sales Q/Q | 11.96% |
| Insider Own | 0.24% | Inst Own | 80.71% |
| Insider Trans | -11.14% | Inst Trans | 0.99% |
| Short Float | 1.56% | Earnings | May 13/a |
| Analyst Recom | 1.89 | Target Price | 126.60 |
| Avg Volume | 22.55M | 52W Range | 62.30 - 119.36 |
|
|
| May-15-26 | Upgrade |
HSBC Securities |
Hold → Buy |
$137 |
|
|
|
Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| OLIVER TUSZIK | Officer | May 15 '26 | Proposed Sale | 115.53 | 2,761 | 318,978 | | May 15 04:33 PM | | DEBORAH STAHLKOPF | Officer | May 15 '26 | Proposed Sale | 115.53 | 6,586 | 760,881 | | May 15 04:23 PM | | JEETENDRA PATEL | Officer | May 15 '26 | Proposed Sale | 115.53 | 7,169 | 828,235 | | May 15 04:23 PM | | MARK PATTERSON | Officer | May 15 '26 | Proposed Sale | 115.53 | 5,512 | 636,801 | | May 15 04:21 PM | | Patterson Mark | EVP and CFO | Mar 20 '26 | Sale | 77.97 | 4,892 | 381,450 | 200,041 | Mar 23 04:28 PM |
|
|
 |
![CXT - Crane NXT Co - Stock Price Chart]() |
| Market Cap | 2.20B | EPS (TTM) | 2.24 |
| P/E | 17.08 | EPS this Y | 4.45% |
| Forward P/E | 8.05 | EPS next Y | 11.89% |
| PEG | 1.10 | EPS past 5Y | -4.06% |
| P/S | 1.28 | EPS next 5Y | 7.29% |
| P/B | 1.77 | EPS Q/Q | -70.57% |
| Dividend | 1.86% | Sales Q/Q | 17.38% |
| Insider Own | 13.72% | Inst Own | 99.19% |
| Insider Trans | 0.00% | Inst Trans | -2.27% |
| Short Float | 13.87% | Earnings | May 06/a |
| Analyst Recom | 1.43 | Target Price | 66.83 |
| Avg Volume | 763.84K | 52W Range | 39.23 - 69.00 |
|
|
| May-15-26 | Upgrade |
Northland Capital |
Market Perform → Outperform |
$52 |
|
|
|
Crane NXT Co. is an industrial technology company, which provides trusted technology solutions to secure, detect, and authenticate to its customers. It operates through the following segments: Crane Payment Innovations (CPI), Security and Authentication Technologies (SAT), and Corporate. The CPI segment offers electronic equipment and associated software leveraging extensive and proprietary core capabilities with various detection and sensing technologies for applications including verification and authentication of payment transactions. The SAT segment focuses on advanced security solutions based on proprietary technology for securing physical products, including banknotes, consumer goods, and industrial products. The company was founded in 2023 and is headquartered in Waltham, MA. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Keayes Samuel | SVP, Security & Auth. Tech. | May 03 '26 | Option Exercise | 0.00 | 813 | 0 | 23,830 | May 05 04:06 PM | | Cristiano Christina | SVP, Chief Financial Officer | Apr 20 '26 | Option Exercise | 0.00 | 3,300 | 0 | 12,798 | Apr 22 04:03 PM | | Shardelow Bianca B. | VP, Controller & CAO | Apr 20 '26 | Option Exercise | 0.00 | 355 | 0 | 4,408 | Apr 22 04:03 PM | | Igoe Paul Gerard | SVP, General Counsel & Sec. | Mar 20 '26 | Option Exercise | 0.00 | 4,739 | 0 | 13,161 | Mar 23 04:26 PM | | Saak Aaron W | CEO | Feb 26 '26 | Option Exercise | 0.00 | 4,059 | 0 | 40,555 | Mar 02 08:32 PM |
|
|
|  |
![CCAP - Crescent Capital BDC Inc - Stock Price Chart]() |
| Market Cap | 410.10M | EPS (TTM) | 0.41 |
| P/E | 27.41 | EPS this Y | -12.71% |
| Forward P/E | 7.38 | EPS next Y | -4.52% |
| PEG | - | EPS past 5Y | -13.95% |
| P/S | 2.80 | EPS next 5Y | -6.07% |
| P/B | 0.61 | EPS Q/Q | -498.96% |
| Dividend | 13.68% | Sales Q/Q | -27.42% |
| Insider Own | 14.75% | Inst Own | 55.68% |
| Insider Trans | 0.04% | Inst Trans | - |
| Short Float | 1.66% | Earnings | May 13/a |
| Analyst Recom | 1.71 | Target Price | 14.36 |
| Avg Volume | 207.32K | 52W Range | 11.80 - 16.29 |
|
|
| May-15-26 | Upgrade |
B. Riley Securities |
Neutral → Buy |
$13.50 |
| May-15-26 | Downgrade |
Oppenheimer |
Outperform → Perform |
|
|
|
|
Crescent Capital BDC, Inc. is a traded business development company, which engages in investing in middle market companies located in the United States. The fund focuses on companies operating across a broad range of sectors. It provides financing in the form of secured debt including first lien, second lien debt, unsecured debt, mezzanine subordinated debt, and equity securities for buyout transactions. The firm acquires controlling interest. The company was founded on February 5, 2015 and is headquartered in Los Angeles, CA. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Lombard Gerhard | Chief Financial Officer | Nov 17 '25 | Buy | 13.34 | 2,000 | 26,683 | 34,284 | Nov 18 04:11 PM | | Bouek Kirill | Controller | Aug 28 '25 | Buy | 15.67 | 200 | 3,133 | 1,057 | Aug 29 04:17 PM | | Barrios Raymond | Managing Director | Aug 25 '25 | Buy | 15.63 | 3,245 | 50,713 | 19,177 | Aug 26 05:22 PM | | UFCW-Northern California Emplo | 10% Owner | May 29 '25 | Sale | 15.31 | 303,980 | 4,653,934 | 3,902,095 | Aug 18 05:39 PM | | UFCW-Northern California Emplo | 10% Owner | Jun 03 '25 | Sale | 14.90 | 109,429 | 1,630,492 | 3,738,095 | Aug 18 05:39 PM |
|
|
 |
![FE - Firstenergy Corp - Stock Price Chart]() |
| Market Cap | 25.35B | EPS (TTM) | 1.84 |
| P/E | 23.81 | EPS this Y | 7.11% |
| Forward P/E | 14.88 | EPS next Y | 7.82% |
| PEG | 1.95 | EPS past 5Y | -0.91% |
| P/S | 1.63 | EPS next 5Y | 7.62% |
| P/B | 2.00 | EPS Q/Q | 12.12% |
| Dividend | 4.24% | Sales Q/Q | 11.61% |
| Insider Own | 0.15% | Inst Own | 95.76% |
| Insider Trans | -4.31% | Inst Trans | 0.61% |
| Short Float | 4.37% | Earnings | Apr 28/a |
| Analyst Recom | 2.06 | Target Price | 52.83 |
| Avg Volume | 4.98M | 52W Range | 39.28 - 52.34 |
|
|
| May-15-26 | Upgrade |
TD Cowen |
Hold → Buy |
$53 |
|
|
|
FirstEnergy Corp. engages in the generation, transmission, and distribution of electricity, energy management and other energy-related services through its subsidiaries. It operates through the following business segments: Regulated Distribution, Regulated Transmission, and Corporate or Other. The Regulated Distribution segment distributes electricity through FirstEnergy's utility operating companies, serving various customers. The Regulated Transmission segment transmits electricity through transmission facilities owned and operated by FirstEnergy's utilities. The Corporate or Other segment reflects corporate support and other costs not charged or attributable to the utilities or transmission companies. The company was founded in 1996 and is headquartered in Akron, OH. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| ONEIL JAMES F | Director | Mar 11 '26 | Sale | 50.60 | 7,945 | 402,041 | 1,869 | Mar 13 05:50 PM | | K. Jon Taylor | SVP, CFO and Strategy | Mar 10 '26 | Sale | 50.94 | 26,800 | 1,365,272 | 119,552 | Mar 12 04:40 PM | | ONEIL JAMES F | Director | Mar 11 '26 | Proposed Sale | 50.60 | 7,945 | 402,042 | | Mar 11 03:31 PM | | Lisowski Jason | VP, Controller & CAO | Mar 06 '26 | Sale | 50.84 | 3,000 | 152,520 | 7,176 | Mar 10 06:22 PM | | Lisowski Jason | VP, Controller & CAO | Mar 06 '26 | Sale | 50.84 | 1,373 | 69,788 | 0 | Mar 10 06:22 PM |
|
|
 |
![ORIC - ORIC Pharmaceuticals Inc - Stock Price Chart]() |
| Market Cap | 843.67M | EPS (TTM) | -1.43 |
| P/E | - | EPS this Y | 1.32% |
| Forward P/E | - | EPS next Y | -6.46% |
| PEG | - | EPS past 5Y | 15.18% |
| P/S | - | EPS next 5Y | -3.36% |
| P/B | 2.03 | EPS Q/Q | 19.76% |
| Dividend | - | Sales Q/Q | - |
| Insider Own | 41.90% | Inst Own | 79.21% |
| Insider Trans | -0.26% | Inst Trans | 13.98% |
| Short Float | 36.60% | Earnings | May 04/a |
| Analyst Recom | 1.19 | Target Price | 20.36 |
| Avg Volume | 1.93M | 52W Range | 4.53 - 14.93 |
|
|
| May-15-26 | Upgrade |
Goldman |
Neutral → Buy |
$15 |
|
|
|
Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Piscitelli Dominic | Chief Financial Officer | Feb 24 '26 | Option Exercise | 4.36 | 52,000 | 226,720 | 120,148 | Feb 26 04:47 PM | | Piscitelli Dominic | Chief Financial Officer | Feb 24 '26 | Sale | 13.51 | 52,000 | 702,686 | 68,148 | Feb 26 04:47 PM | | Dominic Piscitelli | Officer | Feb 24 '26 | Proposed Sale | 13.50 | 52,000 | 702,000 | | Feb 24 04:08 PM | | Heyman Richard A. | Director | Jan 16 '26 | Sale | 12.00 | 3,500 | 42,016 | 41,800 | Jan 20 07:19 PM | | Heyman Richard A. | Director | Jan 16 '26 | Sale | 12.00 | 3,200 | 38,415 | 213,072 | Jan 20 07:19 PM |
|
|
|